Clinical Trial Update: Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating cryoablation in combination with Karelizumab and Apatinib for lung cancer. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Apatinib (apatinib)
• Karelizumab

Snippet

Sponsor: Zhou Chengzhi | Conditions: Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING